雌激素受体α是非功能性垂体腺瘤侵袭性的性别依赖性预测因子:NFPA中SSTR与性激素受体分布
研究回顾性分析164例非功能性垂体腺瘤(NFPA)患者的肿瘤组织,用免疫组化(n=145)和定量RT-PCR(n=106)检测SSTR1、SSTR2、SSTR3、SSTR5、ERα和PR,并与侵袭性指标比较。结果SSTR3在所有NFPA中高表达;ERα免疫反应评分仅与男性患者SSTR2评分相关,低ERα仅与男性患者更高的再干预率和更早再干预相关;ERα缺失联合年龄可预测男性促性腺激素腺瘤患者的再干预。
要点
- SSTR3在所有非功能性垂体腺瘤中丰富表达,可能是药物治疗的潜在靶点。
- ERα免疫反应评分仅与男性患者SSTR2评分相关(男性P<0.001;女性P=0.8)。
- 低ERα仅与男性患者更高的再干预率(P=0.001)和更早再干预(P=0.004)相关。
核心结论
- SSTR3在非功能性垂体腺瘤中丰富表达,因此是药物治疗的潜在靶点。
- ERα缺失联合年轻年龄可能预测非功能性垂体腺瘤组的肿瘤复发。
- 需要在系统性前瞻性研究中进一步验证。
研究设计与样本
- 回顾性比较肿瘤组织的免疫组化(n=145)和定量逆转录聚合酶链反应(n=106)分析结果与侵袭性变量。
- 检测SSTR1、SSTR2、SSTR3、SSTR5、雌激素受体α(ERα)和孕激素受体(PR),用免疫反应评分(IRS)和信使RNA相对量表示。
- 共纳入164例非功能性垂体腺瘤患者,肿瘤组织来自初次手术。
- 所有患者均在同一三级转诊中心接受手术。
主要发现
- SSTR3在所有非功能性垂体腺瘤中免疫组化表达丰富。
- ERα的IRS与SSTR2的IRS仅在男性患者中相关(男性P<0.001;女性P=0.8)。
- 低ERα水平与男性患者更高的再干预率(P=0.001)和更早再干预(P=0.004)相关;女性患者分别为P=0.95和P=0.65。
- ERα缺失联合年龄为男性促性腺激素腺瘤患者的再干预提供了良好的预测模型。
局限性
- 需要在系统性前瞻性研究中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Nonfunctioning pituitary adenomas (NFPAs) are fairly common and require a multidisciplinary approach. Reliable markers of a clinically aggressive course are lacking. Medical treatment is not available, and transsphenoidal surgery is the preferred primary treatment. OBJECTIVE: We aimed to characterize the somatostatin, estrogen, and progesterone receptor distribution for NFPAs and compare it with factors of tumor aggressiveness. DESIGN: Tumor samples for immunohistochemistry (n = 145) and quantitative reverse transcription polymerase chain reaction (n = 106) analyses of somatostatin receptor (SSTR) 1, SSTR2, SSTR3, SSTR5, estrogen receptor α (ERα), and progesterone receptor (PR) were measured by immunoreactive score (IRS) and messenger RNA relative quantity and retrospectively compared with variables of aggressiveness. SETTING: All patients were operated at the same tertiary referral center. PARTICIPANTS: A total of 164 patients with NFPA and tumor tissue from the primary operation were included. RESULTS: SSTR3 was expressed abundantly by immunohistochemistry in all NFPAs. The IRS of ERα correlated with that of SSTR2 in male patients only (males, P < 0.001; females, P = 0.8). Low ERα level was linked to a higher reintervention rate (P = 0.001) and earlier reintervention (P = 0.004) in male patients only (females, P = 0.95 and P = 0.65, respectively). Absence of ERα together with age provided a good prediction model for reintervention in male patients with gonadotroph adenomas. CONCLUSIONS: SSTR3 is expressed abundantly in NFPAs and is therefore a possible target for medical treatment. Absence of ERα together with young age may predict tumor recurrence in groups of NFPAs. Further validation in systematic prospective studies is needed.
引用
- Øystese KA, Casar-Borota O, Normann KR, et al. Estrogen Receptor α, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA. J Clin Endocrinol Metab. 2017. PMID: 28911153. doi:10.1210/jc.2017-00792
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。